Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

181
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

303
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
303
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

29
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
29
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

358
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
358
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

152
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
152
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

276
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
276

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Favorable outcomes of epilepsy with gait-induced seizures after resection of the unilateral supplementary motor area.

Clinical neurophysiology practice·2025
Same author

Pathogenesis of comorbid epilepsy in Alzheimer's disease and use of perampanel, an AMPA receptor inhibitor.

Expert review of neurotherapeutics·2025
Same author

[Epilepsy and Dementia].

No shinkei geka. Neurological surgery·2025
Same author

[Results of surveys on brain-death determination: Report from the Neuroemergency section of the Japanese Society of Neurology].

Rinsho shinkeigaku = Clinical neurology·2025
Same author

[Differentiation Between Epilepsy and Psychogenic Non-epileptic Seizures from the Perspective of Neurology].

Brain and nerve = Shinkei kenkyu no shinpo·2025
Same author

Alterations of Activity in Visual Areas of Left Mesial Temporal Lobe Epilepsy Patients: Evidence from Moving Facial Emotional Tasks.

Annals of neurosciences·2025

Related Experiment Video

Updated: Jun 17, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.0K

[Progress and Challenges in Epilepsy Treatment].

Naoki Akamatsu1

  • 1Department of Neurology, International University of Health and Welfare School of Medicine.

Brain and Nerve = Shinkei Kenkyu No Shinpo
|August 8, 2024
PubMed
Summary

Neurologists have significantly advanced adult epilepsy care in Japan, introducing updated terminology and new anti-seizure medications. Research also focuses on epilepsy treatment during pregnancy and in the elderly, though surgical options remain limited.

More Related Videos

Author Spotlight: Unraveling Neural Communication and Circuit Interactions in Health and Disease
06:55

Author Spotlight: Unraveling Neural Communication and Circuit Interactions in Health and Disease

Published on: November 21, 2024

709
Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

8.9K

Related Experiment Videos

Last Updated: Jun 17, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.0K
Author Spotlight: Unraveling Neural Communication and Circuit Interactions in Health and Disease
06:55

Author Spotlight: Unraveling Neural Communication and Circuit Interactions in Health and Disease

Published on: November 21, 2024

709
Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

8.9K

Area of Science:

  • Neurology
  • Epileptology

Background:

  • Neurologists have been central to adult epilepsy management in Japan for over 60 years.
  • Epileptology terminology in Japan aligns with the International League Against Epilepsy standards.
  • Seizure terminology for temporal lobe epilepsy has evolved, now termed focal impaired awareness seizures.

Purpose of the Study:

  • To review the evolution and current state of adult epilepsy treatment in Japan.
  • To highlight advancements in anti-seizure medications and specialized epilepsy care.
  • To discuss the role of neurologists in ongoing epilepsy research and clinical practice.

Main Methods:

  • Review of historical and current practices in Japanese epileptology.
  • Analysis of terminology changes and adoption of international standards.
  • Overview of available anti-seizure medications and their applications.

Main Results:

  • Significant progress in anti-seizure medication development, including new first-line options.
  • Availability of anti-seizure medications considered safe during pregnancy.
  • Advancements in research and treatment strategies for epilepsy in elderly populations.
  • Limited adoption of epilepsy surgery in Japan despite ongoing advancements.

Conclusions:

  • Neurologists continue to play a vital role in advancing adult epilepsy care in Japan.
  • The field has seen progress in pharmacological treatments and specialized care for specific populations.
  • Further integration of surgical options and continued research are areas for future development.